Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Study Details page appears unchanged. No edits to trial design, eligibility criteria, outcomes, or listed locations were detected.SummaryDifference0.1%

- Check25 days agoChange DetectedA new Locations section has been added, listing the participating sites by state (Arizona, California, Indiana, Maryland, Pennsylvania, Virginia). The page revision shows an update to v3.3.3.SummaryDifference0.8%

- Check33 days agoChange DetectedMinor UI/layout adjustments observed between the two screenshots; core study details such as eligibility criteria, locations, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and layout appear consistent with the study record.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.